Form 8-K - Current report:
SEC Accession No. 0001104659-25-067133
Filing Date
2025-07-11
Accepted
2025-07-11 07:00:51
Documents
16
Period of Report
2025-07-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2520063d4_8k.htm   iXBRL 8-K 31131
2 EXHIBIT 1.1 tm2520063d4_ex1-1.htm EX-1.1 193749
3 EXHIBIT 5.1 tm2520063d4_ex5-1.htm EX-5.1 13752
7 GRAPHIC tm2520063d3_ex5-1img001.jpg GRAPHIC 11662
8 GRAPHIC tm2520063d3_ex5-1img002.jpg GRAPHIC 7394
  Complete submission text file 0001104659-25-067133.txt   482917

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA rytm-20250709.xsd EX-101.SCH 3014
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE rytm-20250709_lab.xml EX-101.LAB 34239
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rytm-20250709_pre.xml EX-101.PRE 22358
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2520063d4_8k_htm.xml XML 3688
Mailing Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116
Business Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116 857-264-4280
RHYTHM PHARMACEUTICALS, INC. (Filer) CIK: 0001649904 (see all company filings)

EIN.: 462159271 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38223 | Film No.: 251117490
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)